GlassScriptPhysician profile
Ramesh B Pamula
NPI 1356382295
$3,530.97
in general payments reported to CMS, 2019-2025
11 companies · $542 in 2025
The $542 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $170 · 2021: $308 · 2022: $886 · 2023: $542 · 2024: $797 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,224.17 | 2019-2025 | Epic, 2nd Gen Centrimag Primary Console, Sjm Regent |
| Abiomed | $880.70 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $486.34 | 2019-2025 | Konect Resilia, Inspiris Resilia Aortic Valve |
| Atricure, INC. | $385.87 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Astrazeneca Pharmaceuticals LP | $206.48 | 2021-2023 | Tagrisso |
| Integra Lifesciences Corporation | $147.68 | 2022 | |
| Hemosonics LLC | $119.44 | 2022 | |
| Baxter Healthcare | $25.19 | 2023 | Hillrom - Life 2000 Ventilation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.73 | 2024 | Lifevest |
| Acera Surgical, INC. | $15.88 | 2019 | |
| Tactile Systems Technology INC | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Pamula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.